ALNY
$ALNY
Alnylam Pharmaceuticals, Inc.
Pioneer in RNA interference therapeutics treating rare genetic diseases.
Healthcare$158.00
-7.00 (-4.24%)
Day Range$156.06 - $163.90
Prev Close$165.00
Analyst Rating
Strong Buy
22 Buy / 8 Hold / 0 Sell
Price Target
$330.54
109.2% upside
Subscribers
0
Tracking this ticker
Latest Report
Analysis from Oct 31, 2026
ALNY: Earnings Beat, Demand Concerns Weigh
Alnylam reported a large Q3 EPS beat and 52% revenue growth, yet shares fell amid slower patient starts and an investigation. This report examines fundamentals, valuation, catalysts and risks.
Oct 31, 2026
Previous Reports
Keep exploring
- draft Alnylam Pharmaceuticals into a free practice contest: How to put the stock you just researched into a contest lineup at no real-money risk
- the healthcare sector brief for context on Alnylam Pharmaceuticals's peers: Today's sector-level news and moves around the stock